SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Omkar Pharmachem informs about company updates

24 Oct 2018 Evaluate

In accordance with the Regulation 40(9) of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, Omkar Pharmachem  has informed about the submission of a Certificate issued by the Practicing Company Secretary, for half year ending on 30th September, 2018 and thereby certifying that all certificates have been issued within thirty days of the date of lodgment for transfer, sub-division, consolidation, renewal, exchange or endorsement of calls/allotment monies of the company.

The above information is a part of company’s filings submitted to BSE.

Omkar Pharmachem Share Price

20.21 -1.06 (-4.98%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 454.70
Indegene 518.55
CMS Info Systems 291.00
JITF Infralogistics 296.40
Sagility 40.13
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×